Comment from Desirae hopper
AnonymousSupportIndividual
Summary: The commenter supports the petition to regulate NarxCare as a Software as a Medical Device (SaMD). They argue that unregulated risk-scoring algorithms can negatively impact patient care and that FDA oversight is necessary to ensure safety, transparency, and clinical validation.
I fully support this petition to have NarxCare regulated as a Software as a Medical Device (SaMD). Unregulated risk-scoring algorithms are directly influencing patient care decisions, sometimes leading to denied treatments or disrupted physician-patient relationships. Patients rely on accurate, transparent, and clinically validated tools—not black-box algorithms—to guide their healthcare.
Requiring FDA oversight will ensure that NarxCare is safe, reliable, and fair, protecting both patients and providers. Without proper regulation, we risk continued harm, increased healthcare costs, and patients being pushed toward unsafe alternatives out of desperation. It’s time to bring accountability, transparency, and evidence-based validation to these systems—our health and safety depend on it.